Between seven and nine COVID-19 vaccines could be approved in the next two years
The world could get seven to nine vaccines over the next two years given historical vaccine success rates and the current pipeline of candidates. The outlook is even more optimistic if the full pipeline of candidates advances toward clinical trials—tripling the likely number of successful vaccines.
To read the article, see “On pins and needles: Will COVID-19 vaccines ‘save the world’?,” July 29, 2020.
Don’t ride so close to me
Only 5 to 8 % of respondents to our May consumer survey said they felt safe—from a health standpoint—using carsharing, ridesharing, public transport, or shared micromobility services. But 81 % feel safe in private vehicles.
To read the article, see “Why shared mobility is poised to make a comeback after the crisis,” July 15, 2020.
Since June, North America and developing markets more pessimistic on economy
In contrast to rising optimism among respondents to our latest McKinsey Global Survey in other regions, respondents in North America and developing markets aren’t feeling hopeful that their home economies will improve in six months.
To read the survey, see “The coronavirus effect on global economic sentiment,” July 27, 2020.
Governments face a USD 30 trillion fiscal gap by 2023
Governments most likely will finance 80 to 90 percent of the estimated $30 trillion fiscal gap through conventional debt, but a thoughtful approach to balance-sheet funding, revenue-stream optimization, and the containment of spending could give them medium- to long-term support in funding the additional debt burden accumulated during the COVID-19 crisis.
To read the article, see “Closing the USD 30 trillion gap: Acting now to manage fiscal deficits during and beyond the COVID-19 crisis,” July 16, 2020.